Fidelity Investments’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $5.3B | Buy |
10,776,436
+983,089
| +10% | +$534M | 0.28% | 48 |
|
|
2025
Q4 | $5.67B | Buy |
9,793,347
+2,199,538
| +29% | +$1.24B | 0.29% | 39 |
|
|
2025
Q3 | $3.68B | Buy |
7,593,809
+3,602,808
| +90% | +$1.68B | 0.19% | 71 |
|
|
2025
Q2 | $1.62B | Sell |
3,991,001
-651,544
| -14% | -$272M | 0.09% | 176 |
|
|
2025
Q1 | $2.31B | Sell |
4,642,545
-1,694,832
| -27% | -$918M | 0.15% | 111 |
|
|
2024
Q4 | $3.3B | Sell |
6,337,377
-1,540,082
| -20% | -$847M | 0.2% | 69 |
|
|
2024
Q3 | $4.87B | Buy |
7,877,459
+1,294,453
| +20% | +$766M | 0.3% | 46 |
|
|
2024
Q2 | $3.64B | Sell |
6,583,006
-334,967
| -5% | -$192M | 0.23% | 64 |
|
|
2024
Q1 | $4.02B | Sell |
6,917,973
-931,572
| -12% | -$523M | 0.27% | 53 |
|
|
2023
Q4 | $4.17B | Sell |
7,849,545
-470,479
| -6% | -$228M | 0.32% | 45 |
|
|
2023
Q3 | $4.21B | Sell |
8,320,024
-890,117
| -10% | -$474M | 0.36% | 41 |
|
|
2023
Q2 | $4.81B | Sell |
9,210,141
-2,143,903
| -19% | -$1.16B | 0.4% | 37 |
|
|
2023
Q1 | $6.54B | Buy |
11,354,044
+194,602
| +2% | +$110M | 0.6% | 21 |
|
|
2022
Q4 | $6.15B | Buy |
11,159,442
+187,914
| +2% | +$99.6M | 0.61% | 20 |
|
|
2022
Q3 | $5.56B | Buy |
10,971,528
+987,695
| +10% | +$553M | 0.58% | 20 |
|
|
2022
Q2 | $5.42B | Sell |
9,983,833
-316,878
| -3% | -$174M | 0.54% | 23 |
|
|
2022
Q1 | $6.08B | Sell |
10,300,711
-800,254
| -7% | -$460M | 0.49% | 24 |
|
|
2021
Q4 | $7.41B | Sell |
11,100,965
-313,678
| -3% | -$196M | 0.55% | 22 |
|
|
2021
Q3 | $6.52B | Buy |
11,414,643
+1,279,984
| +13% | +$703M | 0.52% | 26 |
|
|
2021
Q2 | $5.11B | Sell |
10,134,659
-1,840,322
| -15% | -$868M | 0.4% | 34 |
|
|
2021
Q1 | $5.47B | Sell |
11,974,981
-1,048,006
| -8% | -$500M | 0.47% | 29 |
|
|
2020
Q4 | $6.07B | Buy |
13,022,987
+686,768
| +6% | +$322M | 0.54% | 21 |
|
|
2020
Q3 | $5.45B | Buy |
12,336,219
+715,208
| +6% | +$295M | 0.55% | 25 |
|
|
2020
Q2 | $4.21B | Buy |
11,621,011
+376,531
| +3% | +$126M | 0.46% | 29 |
|
|
2020
Q1 | $3.19B | Sell |
11,244,480
-1,251,745
| -10% | -$395M | 0.44% | 38 |
|
|
2019
Q4 | $4.06B | Sell |
12,496,225
-191,300
| -2% | -$58M | 0.45% | 34 |
|
|
2019
Q3 | $3.7B | Buy |
12,687,525
+240,837
| +2% | +$69M | 0.44% | 33 |
|
|
2019
Q2 | $3.66B | Buy |
12,446,688
+874,107
| +8% | +$241M | 0.43% | 35 |
|
|
2019
Q1 | $3.17B | Buy |
11,572,581
+2,900,868
| +33% | +$722M | 0.38% | 42 |
|
|
2018
Q4 | $1.94B | Buy |
8,671,713
+2,172,574
| +33% | +$510M | 0.27% | 68 |
|
|
2018
Q3 | $1.59B | Buy |
6,499,139
+1,016,082
| +19% | +$234M | 0.18% | 101 |
|
|
2018
Q2 | $1.14B | Sell |
5,483,057
-637,773
| -10% | -$135M | 0.13% | 151 |
|
|
2018
Q1 | $1.26B | Buy |
6,120,830
+837,692
| +16% | +$176M | 0.15% | 138 |
|
|
2017
Q4 | $1B | Sell |
5,283,138
-874,564
| -14% | -$168M | 0.12% | 183 |
|
|
2017
Q3 | $1.17B | Buy |
6,157,702
+2,567,657
| +72% | +$465M | 0.14% | 145 |
|
|
2017
Q2 | $626M | Sell |
3,590,045
-65,002
| -2% | -$10.9M | 0.08% | 265 |
|
|
2017
Q1 | $561M | Sell |
3,655,047
-1,232,458
| -25% | -$188M | 0.07% | 287 |
|
|
2016
Q4 | $690M | Sell |
4,887,505
-3,006,181
| -38% | -$443M | 0.09% | 231 |
|
|
2016
Q3 | $1.26B | Sell |
7,893,686
-322,959
| -4% | -$49.8M | 0.17% | 121 |
|
|
2016
Q2 | $1.21B | Buy |
8,216,645
+834,858
| +11% | +$123M | 0.17% | 130 |
|
|
2016
Q1 | $1.05B | Sell |
7,381,787
-821,794
| -10% | -$110M | 0.14% | 146 |
|
|
2015
Q4 | $1.16B | Sell |
8,203,581
-1,132,421
| -12% | -$151M | 0.16% | 132 |
|
|
2015
Q3 | $1.14B | Sell |
9,336,002
-2,158,889
| -19% | -$281M | 0.16% | 129 |
|
|
2015
Q2 | $1.49B | Sell |
11,494,891
-1,186,866
| -9% | -$155M | 0.19% | 107 |
|
|
2015
Q1 | $1.7B | Buy |
12,681,757
+33,359
| +0.3% | +$4.3M | 0.22% | 88 |
|
|
2014
Q4 | $1.58B | Buy |
12,648,398
+1,645,184
| +15% | +$200M | 0.21% | 101 |
|
|
2014
Q3 | $1.34B | Sell |
11,003,214
-852,498
| -7% | -$104M | 0.18% | 118 |
|
|
2014
Q2 | $1.4B | Sell |
11,855,712
-1,922,385
| -14% | -$226M | 0.19% | 114 |
|
|
2014
Q1 | $1.66B | Buy |
13,778,097
+126,762
| +0.9% | +$15.1M | 0.23% | 87 |
|
|
2013
Q4 | $1.52B | Buy |
13,651,335
+1,492,208
| +12% | +$148M | 0.21% | 99 |
|
|
2013
Q3 | $1.12B | Buy |
12,159,127
+3,238,896
| +36% | +$293M | 0.17% | 126 |
|
|
2013
Q2 | $755M | Buy |
+8,920,231
| New | +$743M | 0.12% | 178 |
|
Other funds holding TMO
VCM
VPM
Fidelity Investments's TMO Position: Q1 2026 in Review
Fidelity Investments increased its Thermo Fisher Scientific (TMO) stake by 10% in Q1 2026, buying an estimated $534M and bringing the position to 10,776,436 shares worth $5.3B. The position accounts for 0.28% of the portfolio, ranked #48.
Fidelity Investments first reported a position in TMO in Q2 2013 and has held it in 52 quarters since. The position peaked at $7.41B in Q4 2021. 2,589 funds tracked by Wall St. Rank hold TMO as of Q1 2026.
- Fidelity Investments held 10,776,436 shares of Thermo Fisher Scientific worth $5.3B as of Q1 2026.
- Fidelity Investments bought 983,089 Thermo Fisher Scientific shares in Q1 2026, an estimated $534M.
- Thermo Fisher Scientific made up 0.28% of Fidelity Investments's portfolio in Q1 2026, its #48 holding.
- Fidelity Investments first reported a position in Thermo Fisher Scientific in Q2 2013 and has held it in 52 quarters since.
- Fidelity Investments's Thermo Fisher Scientific position peaked at $7.41B in Q4 2021.
- 2,589 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.
Based on Fidelity Investments's 13F filing for Q1 2026, filed 15 May 2026.